N-Acetyl (3,4-Dihydroxybutyl) Cysteine: The Urine Marker That Tracks 1,3-Butadiene

REVIEWED BY

William Maish, MD MBA MPH

Clinical Product Lead

Published

Last updated

Key takeaway:

This urine test measures N‑acetyl‑(3,4‑dihydroxybutyl)‑cysteine (DHBMA), a biomarker of 1,3‑butadiene exposure from cigarette smoke, traffic exhaust, and industrial emissions. Identifying and reducing this toxic exposure can help lower your risk of certain cancers and related cardiovascular and respiratory problems.

Read more →

Understand what your environmental toxins results really mean

See your biomarkers in context with a comprehensive panel.

  • CLIA-certified labs
  • HIPAA compliant
  • Personalized health protocol
Book your test

DHBMA and the 1,3-butadiene exposure it tracks

N‑Acetyl (3,4‑Dihydroxybutyl) cysteine is a mouthful, so here’s the plain version: it’s a mercapturic acid in urine that your body makes after encountering 1,3‑butadiene, a common industrial and urban air pollutant. 1,3‑butadiene is a gas used in making synthetic rubber and can be found in vehicle exhaust and tobacco smoke. The body processes that gas, couples reactive byproducts to glutathione (a protective antioxidant), and ultimately excretes these “tagged” fragments in urine. This specific metabolite is often shortened to DHBMA. Labs measure DHBMA in urine, typically by LC‑MS/MS, to reflect recent exposure rather than long‑term body burden.

Why it matters: 1,3‑butadiene can form reactive epoxides that interact with cellular DNA and proteins. Your detox systems—particularly the liver’s phase I and phase II enzymes and the glutathione pathway—work to neutralize and clear these. Elevated DHBMA suggests the body has been busy processing 1,3‑butadiene. While 1,3‑butadiene does not bioaccumulate like some persistent chemicals, repeated or higher exposures can increase system stress over time. Epidemiology and biomonitoring research link higher levels to tobacco smoke and certain workplaces, with regulatory agencies classifying 1,3‑butadiene as a human carcinogen, though individual risk depends on dose, duration, and co‑exposures.

Typical sources include tobacco smoke (active and secondhand), vehicle exhaust in dense traffic, emissions from synthetic rubber production, and other high‑heat combustion settings. Everyday examples: refueling near diesel vehicles, standing close to a smoker outdoors, or spending hours along a busy roadway. Indoor air can contribute if ventilation is poor and a source is present. Diet is not a major driver compared with inhalation for 1,3‑butadiene.

Join 150,000+ others building better health

Get the science behind better health, every week.

By clicking “Subscribe” you agree to our Terms of Service and Privacy Policy.

Why measuring recent 1,3-butadiene exposure matters

Because DHBMA tracks your recent 1,3‑butadiene exposure, a single test can help distinguish a one‑off encounter—think a long day in traffic near idling buses—from an ongoing source like regular secondhand smoke or occupational contact. That clarity can explain why some people notice respiratory irritation, headaches, or fatigue after certain environments, and it can help pinpoint whether the likely contributor is urban air, a specific building, or a work process. Testing is especially informative if you’re pregnant or planning pregnancy, live with smokers, commute through heavy traffic, or work around combustion or synthetic rubber manufacturing. It also helps separate incidental contact from sustained exposure that may warrant closer look with your clinician.

Who benefits most from DHBMA testing

People living with smokers, commuting through heavy traffic, working in or near rubber manufacturing or combustion processes, or navigating pregnancy planning may find DHBMA testing clarifies exposure. It can also be helpful when unexplained headaches or irritant symptoms seem tied to specific places or routines, or when you are evaluating the impact of environmental changes and want objective feedback.

Reading a DHBMA result

Labs typically report DHBMA as a urine concentration, often adjusted to creatinine to account for hydration. Reference ranges are population‑based, not “optimal,” and they describe what’s commonly seen in the general public. For environmental toxins like 1,3‑butadiene, lower values are generally preferable when feasible. Interpretation benefits from knowing your recent exposures—travel, commuting, secondhand smoke, workplace tasks—and, when possible, from repeat testing to confirm a pattern.

Relatively lower DHBMA values usually indicate limited recent 1,3‑butadiene exposure and a lower likelihood of short‑term system stress from this source. That often aligns with non‑smoking households, good ventilation, and limited time in high‑traffic or industrial settings. For pregnancy and early childhood—life stages more sensitive to air pollutants—keeping exposure in the lower end of population norms is generally considered prudent, though individual decisions should be made with a clinician.

Relatively higher DHBMA suggests recent or ongoing exposure. That can reflect tobacco smoke (active or secondhand), urban traffic density, or specific work environments. Biologically, it means the liver and glutathione pathways are processing more of this pollutant, and the kidneys are clearing the resulting conjugates. People may notice respiratory irritation or headaches in parallel with co‑exposures, but the metabolite alone does not diagnose a condition. Because hydration, timing, and lab methods influence results, confirmation with trend data and context is key—especially if values are unexpectedly elevated.

Test 100+ biomarkers from home

One blood draw. A full picture of your health, explained in plain language.

Book your test

What can shift a DHBMA reading

DHBMA reflects recent exposure and cannot pinpoint a single source by itself. Hydration and collection timing influence results. Population ranges describe what is common, not necessarily what is ideal. And while 1,3‑butadiene is a known concern at higher or prolonged exposures, individual risk depends on dose, duration, and co‑exposures—more research is ongoing to refine those relationships. That’s why trend tracking and clinical context are so important.

What to pair with a DHBMA result

Big picture, DHBMA results become more meaningful when viewed alongside patterns in other volatile organic compound (VOC) metabolites, general health markers, and your symptom story. Environmental exposures rarely act in isolation. Watching trends—rather than reacting to a single value—helps you see whether changes in home ventilation, commuting patterns, or workplace practices align with lower biomarker levels. That context is what turns a lab number into health insight.

In the end, DHBMA is most useful alongside related markers and your real life. Pairing it with other VOC metabolites, tobacco smoke biomarkers, and general health indicators helps separate transient spikes from persistent exposure patterns. Over time, that combined view supports smarter environmental choices and more focused clinical discussions without overinterpreting any single result.

Treat the number as a data point, not a diagnosis. Discuss recent exposures, household and workplace context, and whether other biomarkers might round out the picture. In some cases, looking at additional VOC metabolites helps differentiate broad air pollution exposure from a more specific source. Your clinician can also interpret levels in light of overall health, pregnancy status, and any co‑existing conditions, keeping in mind that research continues to evolve.

Frequently Asked Questions

References

  1. Urban M, Gilch G, Schepers G, van Miert E, Scherer G (2003). Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry. *Journal of Chromatography B*, *796*(1), 131-140. https://doi.org/10.1016/j.jchromb.2003.08.009
  2. Park SL, Kotapati S, Wilkens LR, Tiirikainen M, Murphy SE, Tretyakova N, Le Marchand L (2014). 1,3-Butadiene exposure and metabolism among Japanese American, Native Hawaiian, and White smokers. *Cancer Epidemiology, Biomarkers & Prevention*, *23*(11), 2240-2249. https://doi.org/10.1158/1055-9965.EPI-14-0492
  3. Pluym N, Gilch G, Scherer G, Scherer M (2015). Analysis of 18 urinary mercapturic acids by two high-throughput multiplex-LC-MS/MS methods. *Analytical and Bioanalytical Chemistry*, *407*(18), 5463-5476. https://doi.org/10.1007/s00216-015-8719-x
  4. Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL (2005). Urinary creatinine concentrations in the U.S. population: Implications for urinary biologic monitoring measurements. *Environmental Health Perspectives*, *113*(2), 192-200. https://doi.org/10.1289/ehp.7337
  5. Centers for Disease Control and Prevention. (2021). *Fourth national report on human exposure to environmental chemicals, updated tables, March 2021*. https://stacks.cdc.gov/view/cdc/105345

Led by doctors with 40 years of health and longevity expertise

Dr. Anant Vinjamoori

Dr. Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Dr. Leigh Erin Connealy

Dr. Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Dr. Robert Lufkin

Dr. Robert Lufkin, MD

Physician & UCLA Medical School Professor, NYT bestselling author

Dr. Abe Malkin

Dr. Abe Malkin, MD

Founder & Medical Director of Concierge MD

Membership 1
1 / 4

Your membership starts here

Annual 100+ biomarker panel

  • Data dashboard and digital twin
  • Upload past labs and connect wearables
  • Personalized health protocol
  • 24/7 care team access
  • AI companion for all health questions
  • Marketplace with additional solutions
$199
/year*Billed annually
Get started
HSA/FSA eligibleCancel anytimeResults in a week

*Pricing may vary for members in New York and New Jersey